AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib for previously untreated patients with Chronic Lymphocytic Leukemia Ruchika Sharma30 July 2025 11:29 AM ISTVENCLEXTA is being developed by AbbVie and Roche.
Ichnos Glenmark Innovation, AbbVie ink pact for investigational cancer drug Ruchika Sharma11 July 2025 2:54 PM ISTNew York: AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), have announced an...
Premarket approval application for Skinvive by Juvederm for neck lines reduction under USFDA review: Abbvie Allergan Aesthetics Ruchika Sharma2 July 2025 3:03 PM ISTIrvine: AbbVie's Allergan Aesthetics has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the...
USFDA approves expanded indication for AbbVie Mavyret for Acute Hepatitis C Virus Ruchika Sharma15 Jun 2025 12:00 PM ISTNorth Chicago: AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for a label expansion for MAVYRET...
AbbVie Emrelis gets USFDA accelerated approval for a type of lung cancer Ruchika Sharma15 May 2025 11:10 AM ISTNorth Chicago: AbbVie has received accelerated approval from the U.S. Food and Drug Administration (FDA) for EMRELIS (telisotuzumab...
USFDA approves AbbVie giant cell arteritis drug Rinvoq in adults Ruchika Sharma30 April 2025 4:30 PM ISTNorth Chicago, Ill.: AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for RINVOQ (upadacitinib), 15 mg, once daily,...
Abbvie seeks USFDA nod for trenibotulinumtoxinE for glabellar lines treatment Ruchika Sharma25 April 2025 11:46 AM ISTNorth Chicago, Ill.: AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for...
Abbvie CEO Robert A Michael to assume additional role of Board Chairman Ruchika Sharma18 Feb 2025 4:30 PM ISTNorth Chicago: AbbVie has announced that its board of directors has unanimously elected chief executive officer (CEO) Robert A. Michael to assume...
AbbVie gets USFDA nod for Emblaveo for treatment of adults with complicated intra abdominal infections with limited or no treatment option Ruchika Sharma8 Feb 2025 11:30 AM ISTNorth Chicago: AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a...
AbbVie concludes acquisition of Aliada Therapeutics Ruchika Sharma15 Dec 2024 10:00 AM ISTNorth Chicago, Ill: AbbVie has announced that it has completed its acquisition of Aliada Therapeutics. With the completion of the acquisition, Aliada...
AbbVie gets European Commission nod for Elahere for Platinum-Resistant ovarian cancer Ruchika Sharma19 Nov 2024 6:24 PM ISTNorth Chicago: AbbVie has announced the European Commission (EC) has granted marketing authorization for ELAHERE (mirvetuximab soravtansine) for...
AbbVie seeks USFDA accelerated approval for telisotuzumab vedotin for previously treated non small cell lung cancer Ruchika Sharma29 Sept 2024 1:15 PM ISTNorth Chicago: AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for...
